A second mutation associated with apparent beta-hexosaminidase A pseudodeficiency: identification and frequency estimation.
A second mutation associated with apparent beta-hexosaminidase A pseudodeficiency: identification and frequency estimation.
复制标题
与明显的β-己糖胺酶A假性缺陷相关的第二个突变:识别和频率估计。
DOI:
--
复制
发表时间:
1993
影响因子:
9.8
通讯作者:
B. Triggs
中科院分区:
文献类型:
--
作者:
Z. Cao;Marvin R. Natowicz;Michael M. Kaback;J. Lim;E. Prence;David H. Brown;T. Chabot;B. Triggs
Deficient activity of beta-hexosaminidase A (Hex A), resulting from mutations in the HEXA gene, typically causes Tay-Sachs disease. However, healthy individuals lacking Hex A activity against synthetic substrates (i.e., individuals who are pseudodeficient) have been described. Recently, an apparently benign C739-to-T (Arg247Trp) mutation was found among individuals with Hex A levels indistinguishable from those of carriers of Tay-Sachs disease. This allele, when in compound heterozygosity with a second "disease-causing" allele, results in Hex A pseudodeficiency. We examined the HEXA gene of a healthy 42-year-old who was Hex A deficient but did not have the C739-to-T mutation. The HEXA exons were PCR amplified, and the products were analyzed for mutations by using restriction-enzyme digestion or single-strand gel electrophoresis. A G805-to-A (Gly269Ser) mutation associated with adult-onset GM2 gangliosidosis was found on one chromosome. A new mutation, C745-to-T (Arg249Trp), was identified on the second chromosome. This mutation was detected in an additional 4/63 (6%) non-Jewish and 0/218 Ashkenazi Jewish enzyme-defined carriers. Although the Arg249Trp change may result in a late-onset form of GM2 gangliosidosis, any phenotype must be very mild. This new mutation and the benign C739-to-T mutation together account for approximately 38% of non-Jewish enzyme-defined carriers. Because carriers of the C739-to-T and C745-to-T mutations cannot be differentiated from carriers of disease-causing alleles by using the classical biochemical screening approaches, DNA-based analyses for these mutations should be offered for non-Jewish enzyme-defined heterozygotes, before definitive counseling is provided.
登录
查看更多内容
影响因子:
9.8
作者:
Navon,R;Kolodny,EH;Mitsumoto,H;Thomas,GH;Proia,RL
通讯作者:
Proia,RL
DOI:
10.1073/pnas.86.7.2413
发表时间:
1989
影响因子:
11.1
作者:
Paw,BH;Kaback,MM;Neufeld,EF
通讯作者:
Neufeld,EF
影响因子:
9.8
作者:
Triggs-Raine,BL;Mules,EH;Kaback,MM;Lim-Steele,JS;Dowling,CE;Akerman,BR;Natowicz,MR;Grebner,EE;Navon,R;Welch,JP
通讯作者:
Welch,JP
影响因子:
9.8
作者:
Paw,BH;Tieu,PT;Kaback,MM;Lim,J;Neufeld,EF
通讯作者:
Neufeld,EF
影响因子:
9.8
作者:
Grebner,EE;Mansfield,DA;Raghavan,SS;Kolodny,EH;d'Azzo,A;Neufeld,EF;Jackson,LG
通讯作者:
Jackson,LG